These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 23285024)
1. Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization. Imam JS; Plyler JR; Bansal H; Prajapati S; Bansal S; Rebeles J; Chen HI; Chang YF; Panneerdoss S; Zoghi B; Buddavarapu KC; Broaddus R; Hornsby P; Tomlinson G; Dome J; Vadlamudi RK; Pertsemlidis A; Chen Y; Rao MK PLoS One; 2012; 7(12):e52397. PubMed ID: 23285024 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. Li YJ; Wang Y; Wang YY J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-107 inhibits tumor growth and metastasis by targeting the BDNF-mediated PI3K/AKT pathway in human non-small lung cancer. Xia H; Li Y; Lv X Int J Oncol; 2016 Oct; 49(4):1325-33. PubMed ID: 27498977 [TBL] [Abstract][Full Text] [Related]
4. MiR-206 inhibits HGF-induced epithelial-mesenchymal transition and angiogenesis in non-small cell lung cancer via c-Met /PI3k/Akt/mTOR pathway. Chen QY; Jiao DM; Wu YQ; Chen J; Wang J; Tang XL; Mou H; Hu HZ; Song J; Yan J; Wu LJ; Chen J; Wang Z Oncotarget; 2016 Apr; 7(14):18247-61. PubMed ID: 26919096 [TBL] [Abstract][Full Text] [Related]
5. MiR-206 inhibits epithelial ovarian cancer cells growth and invasion via blocking c-Met/AKT/mTOR signaling pathway. Dai C; Xie Y; Zhuang X; Yuan Z Biomed Pharmacother; 2018 Aug; 104():763-770. PubMed ID: 29807226 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-520a-3p inhibits cell growth and metastasis of non-small cell lung cancer through PI3K/AKT/mTOR signaling pathway. Lv X; Li CY; Han P; Xu XY Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2321-2327. PubMed ID: 29762835 [TBL] [Abstract][Full Text] [Related]
7. LncRNA MALAT1 promotes migration and invasion of non-small-cell lung cancer by targeting miR-206 and activating Akt/mTOR signaling. Tang Y; Xiao G; Chen Y; Deng Y Anticancer Drugs; 2018 Sep; 29(8):725-735. PubMed ID: 29916897 [TBL] [Abstract][Full Text] [Related]
8. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis. Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462 [TBL] [Abstract][Full Text] [Related]
9. Plasma-derived exosome miR-10a-5p promotes premature ovarian failure by target BDNF via the TrkB/Akt/mTOR signaling pathway. Bao Z; Li J; Cai J; Yao S; Yang N; Yang J; Zhao B; Chen Y; Wu X Int J Biol Macromol; 2024 Oct; 277(Pt 1):134195. PubMed ID: 39069050 [TBL] [Abstract][Full Text] [Related]
10. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974 [TBL] [Abstract][Full Text] [Related]
11. MiR-99a suppressed cell proliferation and invasion by directly targeting HOXA1 through regulation of the AKT/mTOR signaling pathway and EMT in ovarian cancer. Zhang L; Liu XL; Yuan Z; Cui J; Zhang H Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4663-4672. PubMed ID: 31210292 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-122 promotes proliferation, invasion and migration of renal cell carcinoma cells through the PI3K/Akt signaling pathway. Lian JH; Wang WH; Wang JQ; Zhang YH; Li Y Asian Pac J Cancer Prev; 2013; 14(9):5017-21. PubMed ID: 24175769 [TBL] [Abstract][Full Text] [Related]
13. Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer. Ma T; Chen H; Wang P; Yang N; Bao J Cancer Biother Radiopharm; 2020 Nov; 35(9):661-672. PubMed ID: 32275162 [No Abstract] [Full Text] [Related]
14. Kaempferol inhibits proliferation, migration, and invasion of liver cancer HepG2 cells by down-regulation of microRNA-21. Zhu G; Liu X; Li H; Yan Y; Hong X; Lin Z Int J Immunopathol Pharmacol; 2018; 32():2058738418814341. PubMed ID: 30477356 [TBL] [Abstract][Full Text] [Related]
15. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro. Yan H; Wu W; Ge H; Li P; Wang Z Int J Gynecol Cancer; 2015 Jul; 25(6):944-52. PubMed ID: 25962115 [TBL] [Abstract][Full Text] [Related]
16. miR-126 reduces trastuzumab resistance by targeting PIK3R2 and regulating AKT/mTOR pathway in breast cancer cells. Fu R; Tong JS J Cell Mol Med; 2020 Jul; 24(13):7600-7608. PubMed ID: 32410348 [TBL] [Abstract][Full Text] [Related]
17. NF-κB-mediated miR-650 plays oncogenic roles and activates AKT/ERK/NF-κB pathways by targeting RERG in glioma cells. Jin S; Li X; Dai Y; Li C; Wang D Cell Oncol (Dordr); 2020 Dec; 43(6):1035-1048. PubMed ID: 32986146 [TBL] [Abstract][Full Text] [Related]
18. miR-210-5p promotes epithelial-mesenchymal transition by inhibiting PIK3R5 thereby activating oncogenic autophagy in osteosarcoma cells. Liu W; Jiang D; Gong F; Huang Y; Luo Y; Rong Y; Wang J; Ge X; Ji C; Fan J; Cai W Cell Death Dis; 2020 Feb; 11(2):93. PubMed ID: 32024814 [TBL] [Abstract][Full Text] [Related]
19. miR-199a-5p regulates β1 integrin through Ets-1 to suppress invasion in breast cancer. Li W; Wang H; Zhang J; Zhai L; Chen W; Zhao C Cancer Sci; 2016 Jul; 107(7):916-23. PubMed ID: 27094578 [TBL] [Abstract][Full Text] [Related]